Ignite Creation Date:
2025-12-25 @ 4:06 AM
Ignite Modification Date:
2025-12-26 @ 3:03 AM
Study NCT ID:
NCT03466320
Status:
COMPLETED
Last Update Posted:
2021-05-04
First Post:
2018-02-16
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
DEPLETHINK - LymphoDEPLEtion and THerapeutic Immunotherapy With NKR-2
Sponsor:
Celyad Oncology SA
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-09-18
Start Date Type:
ACTUAL
Primary Completion Date:
2021-02-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-02-01
Completion Date Type:
ACTUAL
First Submit Date:
2018-02-16
First Submit QC Date:
None
Study First Post Date:
2018-03-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-04-30
Last Update Post Date:
2021-05-04
Last Update Post Date Type:
ACTUAL